Institutional Ownership Harmony Biosciences Holdings, Inc. (HRMY)
This table provides information about the institutional ownership of Harmony Biosciences Holdings, Inc. (HRMY). We have compiled data on the 289 institutions that hold shares in the stock, with a total of 46.3 Million shares, which have been reported (via 13F filing form) to have a value of $1.28 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Valor Management LLC
Chicago, IL |
Aug 14, 2025 Q2 2025 |
6,618,033
shares
|
$177 Million
88.32% of portfolio
|
Q4 2024
Reduced 41.01%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
5,835,243
shares
|
$156 Million
0.0% of portfolio
|
Q2 2024
Reduced 1.48%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
5,110,780
shares
|
$137 Million
0.0% of portfolio
|
Q2 2025
Added 8.75%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,629,246
shares
|
$43.6 Million
0.0% of portfolio
|
Q2 2025
Added 3.18%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
1,582,176
shares
|
$42.3 Million
0.01% of portfolio
|
Q2 2025
Added 29.18%
|
|
|
American Century Companies Inc
Kansas City, MO |
Aug 12, 2025 Q2 2025 |
1,501,420
shares
|
$40.2 Million
0.03% of portfolio
|
Q2 2025
Added 16.5%
|
|
|
Lsv Asset Management
Chicago, IL |
Aug 11, 2025 Q2 2025 |
1,488,502
shares
|
$39.8 Million
0.11% of portfolio
|
Q2 2025
Added 24.56%
|
|
|
Marshall Wace, LLP
London, X0 |
Aug 13, 2025 Q2 2025 |
1,209,484
shares
|
$32.4 Million
0.05% of portfolio
|
Q2 2025
Added 36.27%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
1,054,348
shares
|
$28.2 Million
0.0% of portfolio
|
Q2 2025
Added 9.17%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
929,471
shares
|
$24.9 Million
0.04% of portfolio
|
Q2 2025
Added 10.6%
|
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
Aug 13, 2025 Q2 2025 |
906,909
shares
|
$24.3 Million
0.02% of portfolio
|
Q2 2025
Added 127.63%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
758,863
shares
|
$20.3 Million
0.0% of portfolio
|
Q2 2025
Added 15.66%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
720,681
shares
|
$19.3 Million
0.0% of portfolio
|
Q2 2025
Added 109.03%
|
|
|
Massachusetts Financial Services CO
Boston, MA |
Aug 08, 2025 Q2 2025 |
644,530
shares
|
$17.2 Million
0.01% of portfolio
|
Q2 2025
Reduced 14.47%
|
|
|
Boston Partners
Boston, MA |
Aug 07, 2025 Q2 2025 |
605,495
shares
|
$16.2 Million
0.02% of portfolio
|
Q2 2025
New holding
|
|
|
Ven Bio Partners LLC
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
489,194
shares
|
$13.1 Million
16.27% of portfolio
|
Q1 2025
Reduced 9.27%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
484,797
shares
|
$13 Million
0.0% of portfolio
|
Q1 2025
Added 105.53%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
437,841
shares
|
$11.7 Million
0.0% of portfolio
|
Q1 2025
Added 6.45%
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
433,935
shares
|
$11.6 Million
0.0% of portfolio
|
Q2 2025
Added 7.53%
|
|
|
Nomura Holdings Inc
Tokyo, M0 |
Aug 18, 2025 Q2 2025 |
422,919
shares
|
$11.3 Million
0.03% of portfolio
|
Q2 2025
Reduced 0.01%
|
|
|
Invesco Ltd.
Atlanta, GA |
Aug 13, 2025 Q2 2025 |
400,947
shares
|
$10.7 Million
0.0% of portfolio
|
Q2 2025
Reduced 9.63%
|
|
|
Pacer Advisors, Inc.
Malvern, PA |
Aug 12, 2025 Q2 2025 |
380,155
shares
|
$10.2 Million
0.04% of portfolio
|
Q2 2025
Reduced 23.5%
|
|
|
Nan Fung Group Holdings LTD
Central, K3 |
Aug 13, 2025 Q2 2025 |
368,665
shares
|
$9.87 Million
22.09% of portfolio
|
Q4 2022
Reduced 27.85%
|
|
|
Capital Management Corp
|
Jul 28, 2025 Q2 2025 |
352,566
shares
|
$9.43 Million
2.12% of portfolio
|
Q2 2025
Added 3.1%
|
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
314,500
shares
|
$8.42 Million
3.5% of portfolio
|
Q3 2023
Reduced 44.87%
|